Literature DB >> 25151500

Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo.

Simon Kreiser1, Jenny Eckhardt1, Christine Kuhnt1, Marcello Stein1, Lena Krzyzak1, Christine Seitz1, Christine Tucher1, Ilka Knippertz1, Christoph Becker2, Claudia Günther2, Alexander Steinkasserer1, Matthias Lechmann3.   

Abstract

The CD83 molecule (CD83) is a well-known surface marker present on mature dendritic cells (mDC). In this study, we show that CD83 is also expressed on a subset of T cells which mediate regulatory T cell (Treg)-like suppressor functions in vitro and in vivo. Treg-associated molecules including CD25, cytotoxic T lymphocyte antigen-4 (CTLA-4), glucocorticoid-induced TNFR family-related gene (GITR), Helios and neuropilin-1 (NRP-1) as well as forkhead box protein 3 (FOXP3) were specifically expressed by these CD83(+) T cells. In contrast, CD83(-) T cells showed a naive T cell phenotype with effector T cell properties upon activation. Noteworthy, CD83(-) T cells were not able to upregulate CD83 despite activation. Furthermore, CD83(+) T cells suppressed the proliferation and inflammatory cytokine release of CD83(-) T cells in vitro. Strikingly, stimulated CD83(+) T cells released soluble CD83 (sCD83), which has been reported to possess immunosuppressive properties. In vivo, using the murine transfer colitis model we could show that CD83(+) T cells were able to suppress colitis symptoms while CD83(-) T cells possessed effector functions. In addition, this CD83 expression is also conserved on expanded human Treg. Thus, from these studies we conclude that CD83(+) T cells share important features with regulatory T cells, identifying CD83 as a novel lineage marker to discriminate between different T cell populations.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  CD83; Suppression; T cell; Transfer colitis; Treg

Mesh:

Substances:

Year:  2014        PMID: 25151500     DOI: 10.1016/j.imbio.2014.08.005

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  15 in total

1.  Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes.

Authors:  Joe M Horvatinovich; Elizabeth W Grogan; Marcus Norris; Alexander Steinkasserer; Henrique Lemos; Andrew L Mellor; Irina Y Tcherepanova; Charles A Nicolette; Mark A DeBenedette
Journal:  J Immunol       Date:  2017-02-13       Impact factor: 5.422

2.  CD83 expression is essential for Treg cell differentiation and stability.

Authors:  Marina Doebbeler; Christina Koenig; Lena Krzyzak; Christine Seitz; Andreas Wild; Thomas Ulas; Kevin Baßler; Dmitry Kopelyanskiy; Alina Butterhof; Christine Kuhnt; Simon Kreiser; Lena Stich; Elisabeth Zinser; Ilka Knippertz; Stefan Wirtz; Christin Riegel; Petra Hoffmann; Matthias Edinger; Lars Nitschke; Thomas Winkler; Joachim L Schultze; Alexander Steinkasserer; Matthias Lechmann
Journal:  JCI Insight       Date:  2018-06-07

3.  TGF-β1 along with other platelet contents augments Treg cells to suppress anti-FVIII immune responses in hemophilia A mice.

Authors:  Dipica Haribhai; Xiaofeng Luo; Juan Chen; Shuang Jia; Linzheng Shi; Jocelyn A Schroeder; Hartmut Weiler; Richard H Aster; Martin J Hessner; Jianda Hu; Calvin B Williams; Qizhen Shi
Journal:  Blood Adv       Date:  2016-12-13

4.  CD83 orchestrates immunity toward self and non-self in dendritic cells.

Authors:  Andreas B Wild; Lena Krzyzak; Katrin Peckert; Lena Stich; Christine Kuhnt; Alina Butterhof; Christine Seitz; Jochen Mattner; Niklas Grüner; Maximilian Gänsbauer; Martin Purtak; Didier Soulat; Thomas H Winkler; Lars Nitschke; Elisabeth Zinser; Alexander Steinkasserer
Journal:  JCI Insight       Date:  2019-10-17

5.  Epithelial cell-derived CD83 restores immune tolerance in the airway mucosa by inducing regulatory T-cell differentiation.

Authors:  Li-Hua Mo; Xiang-Qian Luo; Gui Yang; Jiang-Qi Liu; Li-Teng Yang; Zhi-Qiang Liu; Shuai Wang; Da-Bo Liu; Zhi-Gang Liu; Ping-Chang Yang
Journal:  Immunology       Date:  2021-02-28       Impact factor: 7.215

Review 6.  Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells.

Authors:  Simona Ronchetti; Erika Ricci; Maria Grazia Petrillo; Luigi Cari; Graziella Migliorati; Giuseppe Nocentini; Carlo Riccardi
Journal:  J Immunol Res       Date:  2015-04-15       Impact factor: 4.818

7.  Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells.

Authors:  Yuetsu Tanaka; Mariko Mizuguchi; Yoshiaki Takahashi; Hideki Fujii; Reiko Tanaka; Takuya Fukushima; Takeaki Tomoyose; Aftab A Ansari; Masataka Nakamura
Journal:  Retrovirology       Date:  2015-07-01       Impact factor: 4.602

8.  A Kinetic Study of CD83 Reveals an Upregulation and Higher Production of sCD83 in Lymphocytes from Pregnant Mice.

Authors:  Katrin Regina Helene Packhäuser; Gleyder Roman-Sosa; Jens Ehrhardt; Diana Krüger; Marek Zygmunt; Damián Oscar Muzzio
Journal:  Front Immunol       Date:  2017-04-26       Impact factor: 7.561

9.  The Major Immediate-Early Protein IE2 of Human Cytomegalovirus Is Sufficient to Induce Proteasomal Degradation of CD83 on Mature Dendritic Cells.

Authors:  Christiane S Heilingloh; Linda Grosche; Mirko Kummer; Petra Mühl-Zürbes; Lisa Kamm; Myriam Scherer; Melanie Latzko; Thomas Stamminger; Alexander Steinkasserer
Journal:  Front Microbiol       Date:  2017-02-01       Impact factor: 5.640

Review 10.  An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase-Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases.

Authors:  Li Bo; Tan Guojun; Guo Li
Journal:  Front Immunol       Date:  2018-06-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.